Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

Autor: Conti, Elisa, Galimberti, Gloria, Tremolizzo, Lucio, Masetto, Alessandro, Cereda, Diletta, Zanchi, Clara, Piazza, Fabrizio, Casati, Marco, Isella, Valeria, Appollonio, Ildebrando, Ferrarese, Carlo
Zdroj: In Neuroscience Letters 2010 486(3):193-196
Databáze: ScienceDirect